ArticleActa oncologica (Stockholm, Sweden)2026
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis.
Aaron Caeyman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.